Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study

IBRYD Study Group

Research output: Contribution to journalComment/debate

Abstract

In the original publication of the article, under acknowledgements, the below author’s names, affiliation information were missing and included in this article. 1. Nicolò Martini (Università degli Studi di Padova, Padua, Italy). 2. Chiara Carrozzi (IRCCS Policlinico San Matteo, Pavia, Italy).

Original languageEnglish
Pages (from-to)689-690
Number of pages2
JournalHeart and Vessels
Volume38
Issue number5
Early online date6 Jan 2023
DOIs
Publication statusPublished - May 2023

Bibliographical note

Publisher Copyright:
© The Author(s) 2023.

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Keywords

  • cardioverter-defibrillator
  • Subcutaneous
  • transvenous
  • Brugada syndrome
  • IBRYD study

Fingerprint

Dive into the research topics of 'Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study'. Together they form a unique fingerprint.

Cite this